SpringerLink
Log in

Map** evidence of Iran diabetes research: protocol for a sco** review

  • Study Protocol
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Background

A considerable amount of research funding goes to diabetes management strategies to improve therapeutic goals and reduce the burden of diabetes. A vast amount of the budget is wasted due to unnecessary studies. A sco** review is a pivotal study to overview the available evidence and avoid research waste. In this review, we will try to find out the scope of available studies on diabetes management interventions, identify associated research gaps, and prioritize future studies.

Method

We will carry out a study using Arksey and O’Malley’s sco** review framework. We will search the Scopus and PubMed databases from 01/01/2015 till 01/01/2020. Only original articles related to pharmacological and non-pharmacological management interventions will be included. These interventional studies should be conducted on the Iranian population. After data extraction, a descriptive data analysis will be used to present information in different charts or tables. We will evaluate related published articles based on their document type, level of evidence, type of diabetes, subject area, interventions types, main findings and outcomes.

Discussion

This study represents the first attempt to sum up available studies related to diabetes management interventions performed in Iran. The results of this study will be useful for all the stakeholders and policy-makers involved in diabetes research. It can help clinicians to be informed about studies on management interventions and can guide scientists eager to diabetes research to choose their future research plans based on diabetes research requirements and gaps.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability

Not applicable.

Abbreviations

MENA:

Middle East and North Africa

PRISMA:

Preferred Reporting Items for Systematic Reviews and Meta-Analyses

DM:

Diabetes mellitus

GDM:

gestational diabetes mellitus

References

  1. International Diabetes Federation. IDF Diabetes Atlas. 9th ed. Brussels, Belgium: International Diabetes Federation; 2019.

    Google Scholar 

  2. Hills S, Halban PA. DIAMAP: a road map for diabetes research in Europe. J Diabetes Sci Technol. 2011;5(3):794–7.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Assembly G. Resolution adopted by the General Assembly on 11 September 2015. 2015, A/RES/69/315 15 September 2015. New York: United Nations. Retrieved March 25 ….

  4. Esteghamati A, et al. Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Scientific Reports. 2017;7(1):13461.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Larijani B. Burden of diabetes in Iran: how will it be affected by lifting of the economic sanctions? Lancet Diabetes Endocrinol. 2016;4(10):810–1.

    Article  PubMed  Google Scholar 

  6. Nyenwe EA, et al. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism. 2011;60(1):1–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Grossman LD, Roscoe R, Shack AR. Complementary and Alternative Medicine for Diabetes. Canadian Journal of Diabetes. 2018;42:S154–61.

    Article  PubMed  Google Scholar 

  8. Raveendran AV, Chacko EC, Pappachan JM. Non-pharmacological Treatment Options in the Management of Diabetes Mellitus. Eur Endocrinol. 2018;14(2):31–9.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Fonseca VA, et al. The American Diabetes Association Diabetes Research Perspective. Diabetes Care. 2012;35(6):1380–7.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374(9683):86–9.

    Article  PubMed  Google Scholar 

  11. Chalmers I, et al. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383(9912):156–65.

    Article  PubMed  Google Scholar 

  12. Hetrick SE, et al. Evidence map**: illustrating an emerging methodology to improve evidence-based practice in youth mental health. J Eval Clin Pract. 2010;16(6):1025–30.

    Article  PubMed  Google Scholar 

  13. Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Info Libr J. 2009;26(2):91–108.

    Article  PubMed  Google Scholar 

  14. Bragge P, et al. The Global Evidence Map** Initiative: sco** research in broad topic areas. BMC medical research methodology. 2011;11:92.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Yiu KC, Rohwer A, Young T. Integration of care for hypertension and diabetes: a sco** review assessing the evidence from systematic reviews and evaluating reporting. BMC Health Services Research. 2018;18(1):481.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Kullgren JT, et al. A Sco** Review of Behavioral Economic Interventions for Prevention and Treatment of Type 2 Diabetes Mellitus. Curr Diab Rep. 2017;17(9):73.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Correia JC, et al. Interventions targeting hypertension and diabetes mellitus at community and primary healthcare level in low- and middle-income countries:a sco** review. BMC Public Health. 2019;19(1):1542.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Viswanathan M, et al. Medication Therapy Management Interventions in Outpatient Settings: A Systematic Review and Meta-analysis. JAMA Internal Medicine. 2015;175(1):76–87.

    Article  PubMed  Google Scholar 

  19. Sturt J, et al. Effective interventions for reducing diabetes distress: systematic review and meta-analysis. International Diabetes Nursing. 2015;12(2):40–55.

    Article  Google Scholar 

  20. Sun Y, et al. Evidence map** of recommendations on diagnosis and therapeutic strategies for diabetes foot: an international review of 22 guidelines. 2019; 100: 153956.

  21. Mohseni M, et al. Challenges of managing diabetes in Iran: meta-synthesis of qualitative studies. BMC Health Services Research. 2020;20(1):534.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Faraji O, et al. Policies and Programs for Prevention and Control of Diabetes in Iran: A Document Analysis. Global journal of health science. 2015;7(6):187–97.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Esmaeili S, et al. An overview of diabetes research achievements during a quarter of a century in Diabetes Research Center. Journal of Diabetes & Metabolic Disorders. 2021.

  24. Fatemeh B, et al. Iran Diabetes Research Roadmap (IDRR) Study; Knowledge Gap in Ge-netic Research on Diabetes Mellitus in Iran: A Review Article. Iranian Journal of Public Health. 2017; 46(Supple 1).

  25. Nasli-Esfahani E, et al. Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran. J Diabetes Metab Disord. 2017;16:9.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Gita S, et al. Iran Diabetes Research Roadmap (IDRR) Study; Trends of Pub-lications in Management of Diabetes in Iran: A Review Article. Iranian Journal of Public Health. 2017; 46(Supple 1).

  27. Anderson S, et al. Asking the right questions: sco** studies in the commissioning of research on the organisation and delivery of health services. Health Res Policy Syst. 2008;6:7.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Arksey H. and O'Malley L. Sco** studies: towards a methodological framework. International journal of social research methodology. 2005’ 8(1):19-32.

  29. Peters MD, et al. Guidance for conducting systematic sco** reviews. Int J Evid Based Healthc. 2015;13(3):141–6.

    Article  PubMed  Google Scholar 

  30. Mays N, et al. Synthesising research evidence. 2001; 220.

  31. Moher D, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Clinical research ed.); 2009. 339: b2535-b2535.

Download references

Acknowledgements

Not applicable.

Funding

This research received a grant (grant number:1398-1-97-974) from Endocrinology and Metabolism of Research Institute, Tehran University of Medical Sciences.

Author information

Authors and Affiliations

  1. Diabetes Research Center, Endocrinology and Metabolism Clinical sciences Institute, Tehran University of Medical Sciences, PO Box: 1411413137, Tehran, Iran

    Shahnaz Esmaeili, Fatemeh Bandarian & Ensieh Nasli-Esfahani

  2. Personalized medicine research center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran

    Farideh Razi

  3. Chronic disease research center. Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran

    Nazli Namazi

  4. Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran

    Behnaz Esmaeili

  5. Elderly health research center. Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran

    Mahnaz Sanjari

  6. Biosensor research center. Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran

    Ali Tootee

  7. Metabolic Disorders Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran

    Saeedeh Saeedi

  8. Metabolomics and Genomics Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran

    Camelia Rambod

  9. Evidence Based Medicine Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran

    Maryam Aalaa

  10. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical, Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Bagher Larijani

Authors
  1. Shahnaz Esmaeili
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fatemeh Bandarian
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Farideh Razi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nazli Namazi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Behnaz Esmaeili
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mahnaz Sanjari
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ali Tootee
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Saeedeh Saeedi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Camelia Rambod
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Maryam Aalaa
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Bagher Larijani
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Ensieh Nasli-Esfahani
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

E.NE. B.L conceptualized the study.

SHE designed the data collection methods and wrote the draft proposal of the study under the supervision of ENE.

F.R, N.N, M.S, M.A, F.B, A.T, S.S, C.R, B.E: designed the data collection methods.

Corresponding author

Correspondence to Ensieh Nasli-Esfahani.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests statement

The authors declare no competing interests.

Ethics approval

This study was approved by the ethical committee of Tehran University of Medical Sciences (IR.TUMS.EMRIREC. 1399.004).

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Esmaeili, S., Bandarian, F., Razi, F. et al. Map** evidence of Iran diabetes research: protocol for a sco** review. J Diabetes Metab Disord 21, 2017–2021 (2022). https://doi.org/10.1007/s40200-021-00932-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40200-021-00932-x

Keywords

Search

Navigation